Shanghai Kehua Bio-Engineering Co Ltd (002022) - Total Liabilities

Latest as of September 2025: CN¥1.47 Billion CNY ≈ $214.65 Million USD

Based on the latest financial reports, Shanghai Kehua Bio-Engineering Co Ltd (002022) has total liabilities worth CN¥1.47 Billion CNY (≈ $214.65 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shanghai Kehua Bio-Engineering Co Ltd operating cash flow efficiency to assess how effectively this company generates cash.

Shanghai Kehua Bio-Engineering Co Ltd - Total Liabilities Trend (2001–2024)

This chart illustrates how Shanghai Kehua Bio-Engineering Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Shanghai Kehua Bio-Engineering Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Shanghai Kehua Bio-Engineering Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Kehua Bio-Engineering Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
I-Mab
NASDAQ:IMAB
USA $18.50 Million
Hampidjan hf
IC:HAMP
Iceland Ikr271.63 Million
Huchems
KO:069260
Korea ₩259.89 Billion
Fujian SBS Zipper Science Tech
SHE:002098
China CN¥761.66 Million
Banco Santander Brasil SA
BA:BSBR
Argentina AR$1.14 Trillion
Tianyang Hot Mel
SHG:603330
China CN¥872.42 Million
Funeng Oriental Equipment Technology Co Ltd
SHE:300173
China CN¥2.68 Billion
Jiangling Motors Corp Ltd
SHE:200550
China HK$20.49 Billion

Liability Composition Analysis (2001–2024)

This chart breaks down Shanghai Kehua Bio-Engineering Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 002022 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.47 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Kehua Bio-Engineering Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Kehua Bio-Engineering Co Ltd (2001–2024)

The table below shows the annual total liabilities of Shanghai Kehua Bio-Engineering Co Ltd from 2001 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥1.25 Billion
≈ $183.46 Million
-31.25%
2023-12-31 CN¥1.82 Billion
≈ $266.84 Million
-38.42%
2022-12-31 CN¥2.96 Billion
≈ $433.31 Million
+62.35%
2021-12-31 CN¥1.82 Billion
≈ $266.90 Million
-12.23%
2020-12-31 CN¥2.08 Billion
≈ $304.09 Million
+104.87%
2019-12-31 CN¥1.01 Billion
≈ $148.43 Million
-5.53%
2018-12-31 CN¥1.07 Billion
≈ $157.12 Million
+68.70%
2017-12-31 CN¥636.48 Million
≈ $93.14 Million
+50.66%
2016-12-31 CN¥422.47 Million
≈ $61.82 Million
+22.11%
2015-12-31 CN¥345.97 Million
≈ $50.63 Million
+114.37%
2014-12-31 CN¥161.39 Million
≈ $23.62 Million
-0.43%
2013-12-31 CN¥162.08 Million
≈ $23.72 Million
-18.57%
2012-12-31 CN¥199.05 Million
≈ $29.13 Million
+13.17%
2011-12-31 CN¥175.89 Million
≈ $25.74 Million
+13.06%
2010-12-31 CN¥155.58 Million
≈ $22.77 Million
+16.95%
2009-12-31 CN¥133.03 Million
≈ $19.47 Million
+42.18%
2008-12-31 CN¥93.56 Million
≈ $13.69 Million
-25.84%
2007-12-31 CN¥126.16 Million
≈ $18.46 Million
+45.91%
2006-12-31 CN¥86.46 Million
≈ $12.65 Million
+13.29%
2005-12-31 CN¥76.32 Million
≈ $11.17 Million
+20.16%
2004-12-31 CN¥63.51 Million
≈ $9.29 Million
-22.84%
2003-12-31 CN¥82.31 Million
≈ $12.04 Million
+3.81%
2002-12-31 CN¥79.29 Million
≈ $11.60 Million
+115.22%
2001-12-31 CN¥36.84 Million
≈ $5.39 Million
--

About Shanghai Kehua Bio-Engineering Co Ltd

SHE:002022 China Medical Devices
Market Cap
$456.11 Million
CN¥3.12 Billion CNY
Market Cap Rank
#13087 Global
#4133 in China
Share Price
CN¥6.06
Change (1 day)
+2.02%
52-Week Range
CN¥5.42 - CN¥8.06
All Time High
CN¥29.42
About

Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of in vitro diagnostic reagents and medical testing equipment and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated co… Read more